Pathlab is now able to offer FIB-4 Index as a requestable test.
The FIB-4 Index is used to assess the risk of liver fibrosis in patients with Metabolic Associated Fatty Liver Disease (but is not appropriate for other causes of liver disease).
FIB-4 Index is a calculation which uses the patient’s age, and AST, ALT, and platelet results. Please see the Pathlab test website for FIB-4 limits and comments, which have been adopted from the Auckland Region Gastroenterology group.
If using Pathlab Éclair orders, please go to the additional tab and search “FIB-4.”
The purpose of the Waikato Support to Screening - cervical service is to provide targeted follow-up, community outreach and support to priority group women, and people with a cervix, who have barriers to accessing cervical screening.
Read morePathlab is changing its coeliac disease testing algorithm and will no longer perform upfront total IgA testing on all coeliac requests. From 11 November 2025, total IgA will only be added when results suggest possible IgA deficiency, with anti-DGP IgG continuing to be added automatically when IgA is <0.05 g/L. This updated approach aligns with published evidence and current practice at Canterbury Health Laboratories.
Read moreThe B4 School Check (B4SC) is a universal, comprehensive check for all four-year-old’s that includes height and weight, vision and hearing, immunisations, oral health, and behavioral and developmental components.
View detailsNational Cervical Screening Programme screening updates.